• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身性微肌营养不良蛋白基因递送改善了老年营养不良性mdx小鼠的骨骼肌结构和功能。

Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice.

作者信息

Gregorevic Paul, Blankinship Michael J, Allen James M, Chamberlain Jeffrey S

机构信息

Department of Neurology, University of Washington, Seattle, Washington 98195-7720, USA.

出版信息

Mol Ther. 2008 Apr;16(4):657-64. doi: 10.1038/mt.2008.28. Epub 2008 Mar 4.

DOI:10.1038/mt.2008.28
PMID:18334986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2650831/
Abstract

Restoring dystrophin expression in the muscles of patients with Duchenne muscular dystrophy (DMD) may halt or reverse the degenerative wasting and weakness that causes premature death. However, the therapeutic efficacy of an intervention may be limited by the extent of disease progression prior to treatment. In this study, we considered the potential for ameliorating the pathology in a mouse model of advanced-stage muscular dystrophy by systemic administration of recombinant adeno-associated viral (rAAV6) vectors encoding a microdystrophin expression construct. The treatment of 20-month-old mdx mice restored body-wide expression of a dystrophin-based protein in striated musculature. In aged mice that received treatment, the resultant dystrophin expression was associated with improved hindlimb and respiratory muscle morphology and function, concomitant with reduced muscle fiber degeneration. The findings demonstrate that an established dystrophic state remains amenable to improvement with appropriate intervention and, by some measures, may even achieve benefits similar to those observed with intervention early in disease progression. The capacity to ameliorate the pathology in an animal model of advanced-stage muscular dystrophy suggests that interventions ultimately proven to exert a therapeutic effect in young patients may offer benefits to older patients or those with advanced conditions of progressive muscular dystrophy.

摘要

在杜兴氏肌营养不良症(DMD)患者的肌肉中恢复肌营养不良蛋白的表达,可能会阻止或逆转导致过早死亡的退行性消瘦和肌无力。然而,一种干预措施的治疗效果可能会受到治疗前疾病进展程度的限制。在本研究中,我们考虑了通过全身注射编码微肌营养不良蛋白表达构建体的重组腺相关病毒(rAAV6)载体,来改善晚期肌营养不良症小鼠模型病理状况的可能性。对20月龄的mdx小鼠进行治疗后,在横纹肌组织中恢复了基于肌营养不良蛋白的蛋白质在全身的表达。在接受治疗的老龄小鼠中,由此产生的肌营养不良蛋白表达与后肢和呼吸肌形态及功能的改善相关,同时肌肉纤维变性减少。这些发现表明,既定的营养不良状态通过适当干预仍可得到改善,并且从某些指标来看,甚至可能获得与疾病进展早期干预所观察到的益处相似的效果。在晚期肌营养不良症动物模型中改善病理状况的能力表明,最终被证明对年轻患者有治疗作用的干预措施,可能会对老年患者或患有进行性肌营养不良症晚期的患者有益。

相似文献

1
Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice.全身性微肌营养不良蛋白基因递送改善了老年营养不良性mdx小鼠的骨骼肌结构和功能。
Mol Ther. 2008 Apr;16(4):657-64. doi: 10.1038/mt.2008.28. Epub 2008 Mar 4.
2
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.将包含 dystrophin 卷曲螺旋结构域 C 端螺旋 1 的 AAV2/9-microdystrophin 基因递送到 mdx 小鼠的骨骼肌中,可改善肌肉病理学,并恢复 α1- 连接蛋白和 α- dystrobrevin 的水平。
Hum Gene Ther. 2011 Nov;22(11):1379-88. doi: 10.1089/hum.2011.020. Epub 2011 May 25.
3
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.人源抗肌萎缩蛋白嵌合(DEC)细胞治疗对杜氏肌营养不良症心脏、呼吸和骨骼肌功能改善的长期保护作用。
Stem Cell Rev Rep. 2022 Dec;18(8):2872-2892. doi: 10.1007/s12015-022-10384-2. Epub 2022 May 19.
4
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.mdx和dko营养不良小鼠以及杜氏肌营养不良症患者骨骼肌中Notch信号通路的改变。
Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.
5
rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles.重组腺相关病毒6型-微肌营养不良蛋白可挽救杜氏肌营养不良症小鼠骨骼肌中异常的高尔基体结构。
Traffic. 2007 Oct;8(10):1424-39. doi: 10.1111/j.1600-0854.2007.00622.x. Epub 2007 Aug 20.
6
Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.使用整合型腺病毒-逆转录病毒杂交载体进行稳定的微肌营养不良蛋白基因转移可改善mdx小鼠肌肉的营养不良病理状况。
Hum Mol Genet. 2002 Jul 15;11(15):1719-30. doi: 10.1093/hmg/11.15.1719.
7
Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.人源微小肌营养不良蛋白在转基因 mdx 小鼠中的长期作用改善肌肉生理功能。
FASEB J. 2021 Jun;35(6):e21628. doi: 10.1096/fj.202100057RR.
8
In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.体内基因组编辑可恢复营养不良小鼠的肌营养不良蛋白表达和心脏功能。
Circ Res. 2017 Sep 29;121(8):923-929. doi: 10.1161/CIRCRESAHA.117.310996. Epub 2017 Aug 8.
9
Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.肌营养不良蛋白和肌营养相关蛋白基因转移对免疫健全的肌营养不良(mdx)小鼠的不同影响。
Physiol Genomics. 2000 Sep 8;3(3):133-44. doi: 10.1152/physiolgenomics.2000.3.3.133.
10
Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice.腺相关病毒载体基因转移以及144 kDa微小抗肌萎缩蛋白的肌膜表达可有效恢复抗肌萎缩蛋白相关蛋白复合体,并抑制裸鼠/mdx小鼠的肌纤维变性。
Hum Mol Genet. 2002 Apr 1;11(7):733-41. doi: 10.1093/hmg/11.7.733.

引用本文的文献

1
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects.腺相关病毒微小肌营养不良蛋白基因替代疗法治疗杜氏肌营养不良症:进展与前景
Gene Ther. 2025 Aug 15. doi: 10.1038/s41434-025-00561-6.
2
Expression and function of four AAV-based constructs for dystrophin restoration in the mdx mouse model of Duchenne muscular dystrophy.四种基于 AAV 的构建体在 Duchenne 肌营养不良症 mdx 小鼠模型中用于修复肌营养不良蛋白的表达和功能。
Biol Open. 2023 Sep 15;12(9). doi: 10.1242/bio.059797.
3
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials.微小肌营养不良蛋白表达作为杜氏肌营养不良症临床试验的替代终点。
Hum Gene Ther. 2023 May;34(9-10):404-415. doi: 10.1089/hum.2022.190. Epub 2023 Mar 14.
4
Eccentric contraction-induced strength loss in dystrophin-deficient muscle: Preparations, protocols, and mechanisms.营养不良性肌病中离心收缩诱导的力量损失:制备方法、方案和机制。
J Gen Physiol. 2023 Feb 6;155(2). doi: 10.1085/jgp.202213208. Epub 2023 Jan 18.
5
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy.评价系统性 AAV-微肌营养不良蛋白基因疗法在 Duchenne 肌营养不良症 GRMD 模型中的作用。
Sci Transl Med. 2023 Jan 4;15(677):eabo1815. doi: 10.1126/scitranslmed.abo1815.
6
Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model.腺相关病毒微肌营养不良蛋白基因治疗在杜氏肌营养不良症小鼠模型中的长期疗效。
Hum Gene Ther. 2023 May;34(9-10):449-458. doi: 10.1089/hum.2022.181. Epub 2023 May 2.
7
Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy.确定作为杜氏肌营养不良治疗策略的上调抗肌萎缩蛋白A的FDA批准药物。
Methods Mol Biol. 2023;2587:495-510. doi: 10.1007/978-1-0716-2772-3_26.
8
Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury.盐皮质激素受体信号在肌肉萎缩症和急性损伤的炎症性骨骼肌微环境中的作用
Front Pharmacol. 2022 Jun 28;13:942660. doi: 10.3389/fphar.2022.942660. eCollection 2022.
9
gene transfer in older mice with severe muscular dystrophy restores muscle function and greatly improves survival.年老的严重肌肉萎缩症小鼠中的基因转移恢复肌肉功能,并大大提高存活率。
Sci Adv. 2022 May 27;8(21):eabn0379. doi: 10.1126/sciadv.abn0379. Epub 2022 May 25.
10
Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model.在一个老年临床前 DMD 动物模型中,比较基因编辑和基因替换后肌营养不良蛋白的表达。
Mol Ther. 2022 Jun 1;30(6):2176-2185. doi: 10.1016/j.ymthe.2022.02.003. Epub 2022 Feb 8.

本文引用的文献

1
Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions.营养不良性肌萎缩(mdx)肌肉中的分支纤维与拉长收缩后力量丧失有关。
Am J Physiol Cell Physiol. 2007 Sep;293(3):C985-92. doi: 10.1152/ajpcell.00128.2007. Epub 2007 Jun 13.
2
Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.肌营养不良蛋白缺陷的mdx小鼠寿命缩短,且易患自发性横纹肌肉瘤。
FASEB J. 2007 Jul;21(9):2195-204. doi: 10.1096/fj.06-7353com. Epub 2007 Mar 14.
3
Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.用于治疗肌肉萎缩症的病毒介导基因疗法:成功、局限与最新进展
Biochim Biophys Acta. 2007 Feb;1772(2):243-62. doi: 10.1016/j.bbadis.2006.09.007. Epub 2006 Sep 26.
4
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.重组腺相关病毒6型-微肌营养不良蛋白可保留严重营养不良小鼠的肌肉功能并延长其寿命。
Nat Med. 2006 Jul;12(7):787-9. doi: 10.1038/nm1439. Epub 2006 Jul 2.
5
Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.日本犬X连锁型肌营养不良症(CXMDJ)的主要临床和组织病理学特征
Acta Myol. 2005 Oct;24(2):145-54.
6
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.杜兴氏肌营养不良症mdx小鼠模型的全身基因治疗
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3758-63. doi: 10.1073/pnas.0508917103. Epub 2006 Feb 24.
7
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.吗啉代寡核苷酸的全身递送可恢复全身的抗肌萎缩蛋白表达并改善营养不良性病理。
Nat Med. 2006 Feb;12(2):175-7. doi: 10.1038/nm1345. Epub 2006 Jan 29.
8
Differential proteome analysis of aging in rat skeletal muscle.大鼠骨骼肌衰老的差异蛋白质组分析
FASEB J. 2005 Jul;19(9):1143-5. doi: 10.1096/fj.04-3084fje. Epub 2005 Apr 14.
9
Identification of a molecular signature of sarcopenia.肌少症分子特征的鉴定。
Physiol Genomics. 2005 Apr 14;21(2):253-63. doi: 10.1152/physiolgenomics.00249.2004. Epub 2005 Feb 1.
10
Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.腺相关病毒介导的微肌营养不良蛋白表达可保护年轻的mdx小鼠肌肉免受收缩诱导的损伤。
Mol Ther. 2005 Feb;11(2):245-56. doi: 10.1016/j.ymthe.2004.09.013.